Verdibliss Hemorrhoid Relief Ointments Ointment
NDC Package 76986-034-01
Package Information
Verdibliss Hemorrhoid Relief Ointments (lidocaine, phenylephrine) ointment is temporarily relieves pain, itching, and burning. This formulation utilizes a ointment delivery system. Marketed by Guangdong Quadrant Ecological Technology Co., Ltd., this product is identified by NDC 76986-034 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 2672354 - lidocaine 5 % / phenylephrine HCl 0.25 % Rectal Ointment
- RxCUI: 2672354 - lidocaine 0.05 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment
- RxCUI: 2672354 - lidocaine 5 % / phenylephrine hydrochloride 0.25 % Rectal Ointment
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Local Anesthesia - [PE] (Physiologic Effect)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 76986 - Guangdong Quadrant Ecological Technology Co., Ltd.
- 76986-034 - Verdibliss Hemorrhoid Relief Ointments
- 76986-034-01 - 42.5 g in 1 BOTTLE
- 76986-034 - Verdibliss Hemorrhoid Relief Ointments
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76986-034-01 identifies a specific commercial package of 42.5 g in 1 bottle of Verdibliss Hemorrhoid Relief Ointments, a human over the counter drug labeled by Guangdong Quadrant Ecological Technology Co., Ltd.. This ointment is formulated for rectal use and contains lidocaine; phenylephrine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangdong Quadrant Ecological Technology Co., Ltd. on April 10, 2026. The current certification is valid through December 31, 2027.
How is this Guangdong Quadrant Ecological Technology Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76986003401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.